Promentis Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2020-07-17
- Lead Sponsor
- Promentis Pharmaceuticals, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT03887429
- Locations
- 🇺🇸
Celerion Inc., Lincoln, Nebraska, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
A Study in Patients With Trichotillomania
- First Posted Date
- 2019-01-09
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Promentis Pharmaceuticals, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT03797521
- Locations
- 🇺🇸
CNRI- Los Angeles, Pico Rivera, California, United States
🇺🇸Artemis Institute for Clinical Research, Riverside, California, United States
🇺🇸Behavioral Clinical Research, North Miami, Florida, United States
Randomized, Double-Blind, Placebo-Controlled, MAD Study to Assess the Safety, Tolerability, and Pharmacokinetics of SXC 2023
- First Posted Date
- 2018-05-31
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- Promentis Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03542435
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers
- First Posted Date
- 2017-10-04
- Last Posted Date
- 2019-09-26
- Lead Sponsor
- Promentis Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03301298
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
News
No news found